FATE
Fate Therapeutics Inc
Price:  
3.84 
USD
Volume:  
1,298,369.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FATE Relative Valuation

-1321.8%
Upside

As of 2024-06-25, the Relative Valuation of Fate Therapeutics Inc (FATE) is (46.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.84 USD, the upside of Fate Therapeutics Inc based on Relative Valuation is -1321.8%.

The range of the Relative Valuation is (50.76) - (48.25) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 30.4x - 30.5x 30.4x
Forward P/E multiples 22.6x - 28.9x 25.8x
Fair Price (50.76) - (48.25) (46.92)
Upside -1421.8% - -1356.6% -1321.8%
3.84 USD
Stock Price
(46.92) USD
Fair Price

FATE Relative Valuation - Historical P/E Data

Date P/E
2024-06-24 -2.30
2024-06-21 -2.25
2024-06-20 -2.15
2024-06-18 -2.04
2024-06-17 -2.14
2024-06-14 -2.16
2024-06-13 -2.25
2024-06-12 -2.26
2024-06-11 -2.33
2024-06-10 -2.31
2024-06-07 -2.20
2024-06-06 -2.28
2024-06-05 -2.25
2024-06-04 -2.19
2024-06-03 -2.20
2024-05-31 -2.20
2024-05-30 -2.07
2024-05-29 -2.05
2024-05-28 -2.12
2024-05-24 -2.11
2024-05-23 -2.05
2024-05-22 -2.19
2024-05-21 -2.22
2024-05-20 -2.34
2024-05-17 -2.34
2024-05-16 -2.48
2024-05-15 -2.54
2024-05-14 -2.53
2024-05-13 -2.49
2024-05-10 -2.44
2024-05-09 -2.34
2024-05-08 -2.22
2024-05-07 -2.32
2024-05-06 -2.53
2024-05-03 -2.43
2024-05-02 -2.46
2024-05-01 -2.45
2024-04-30 -2.37
2024-04-29 -2.42
2024-04-26 -2.28
2024-04-25 -2.32
2024-04-24 -2.58
2024-04-23 -2.72
2024-04-22 -2.86
2024-04-19 -2.87
2024-04-18 -3.02
2024-04-17 -3.16
2024-04-16 -3.22
2024-04-15 -3.38
2024-04-12 -3.46